23.03.2026 Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trialmore about Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
23.03.2026 Meduni Vienna: Updated treatment recommendations for rheumatoid arthritismore about Meduni Vienna: Updated treatment recommendations for rheumatoid arthritis
23.03.2026 myBIOS and Olon partner to advance sustainable protein produtionmore about myBIOS and Olon partner to advance sustainable protein prodution
20.03.2026 Eveliqure and Serum Institute of India Announce Strategic Collaboration on the Development of Anti-Diarrhoeal Vaccinesmore about Eveliqure and Serum Institute of India Announce Strategic Collaboration on the Development of Anti-Diarrhoeal Vaccines
20.03.2026 From pathology image to biological discovery: A journey with LazySlidemore about From pathology image to biological discovery: A journey with LazySlide
20.03.2026 Erbe Elektromedizin Wins Microsoft Intelligent Manufacturing Award 2026 in Partnership with Flinn for AI-Powered Evidence Platformmore about Erbe Elektromedizin Wins Microsoft Intelligent Manufacturing Award 2026 in Partnership with Flinn for AI-Powered Evidence Platform
20.03.2026 Boehringer Ingelheim RCV wächst deutlich und stärkt Position in Humanpharma und Tiergesundheitmore about Boehringer Ingelheim RCV wächst deutlich und stärkt Position in Humanpharma und Tiergesundheit
19.03.2026 PIUR IMAGING Launches AI-Powered Software Reducing Thyroid Ultrasound Workflow Time by up to 60%more about PIUR IMAGING Launches AI-Powered Software Reducing Thyroid Ultrasound Workflow Time by up to 60%
19.03.2026 Marinomed Biotech Announces Capital increase with subscription rightsmore about Marinomed Biotech Announces Capital increase with subscription rights
19.03.2026 Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 millionmore about Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 million